Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Benoit J. Arsenault
Laval University
Publications 192
Published on Jul 1, 2019in The Lancet Diabetes & Endocrinology 24.54
Ian J. Neeland22
Estimated H-index: 22
(UTSW: University of Texas Southwestern Medical Center),
Robert Ross47
Estimated H-index: 47
(Queen's University)
+ 14 AuthorsBenoit J. Arsenault34
Estimated H-index: 34
(Laval University)
Summary Findings from epidemiological studies over the past 30 years have shown that visceral adipose tissue, accurately measured by CT or MRI, is an independent risk marker of cardiovascular and metabolic morbidity and mortality. Emerging evidence also suggests that ectopic fat deposition, including hepatic and epicardial fat, might contribute to increased atherosclerosis and cardiometabolic risk. This joint position statement from the International Atherosclerosis Society and the International...
Kang H. Zheng1
Estimated H-index: 1
(UvA: University of Amsterdam),
Benoit J. Arsenault34
Estimated H-index: 34
(Laval University)
+ -3 AuthorsS. Matthijs Boekholdt56
Estimated H-index: 56
(UvA: University of Amsterdam)
Background Apolipoprotein B/apolipoprotein A‐I (apoB/apoA‐I) ratio and lipoprotein(a) (Lp[a]) are associated with aortic valve stenosis (AVS) disease progression. Clinical characteristics such as a...
Published on May 29, 2019in JAMA Cardiology
Nicolas Perrot2
Estimated H-index: 2
(Laval University),
Sébastien Thériault11
Estimated H-index: 11
(Laval University)
+ 23 AuthorsThierry Le Tourneau31
Estimated H-index: 31
(French Institute of Health and Medical Research)
Importance Genetic variants at the LPA locus are associated with both calcific aortic valve stenosis (CAVS) and coronary artery disease (CAD). Whether these variants are associated with CAVS in patients with CAD vs those without CAD is unknown. Objective To study the associations of LPA variants with CAVS in a cohort of patients undergoing heart surgery and LPA with CAVS in patients with CAD vs those without CAD and to determine whether first-degree relatives of patients with CAVS and high lipop...
Marjorie Bastien7
Estimated H-index: 7
(Laval University),
Paul Poirier53
Estimated H-index: 53
(Laval University)
+ 5 AuthorsMarie-Ève Piché15
Estimated H-index: 15
(Laval University)
Targeting metabolic determinants of exercise performance with pharmacological agents that would mimic/potentiate the effects of exercise represents an attractive clinical alternative to counterbala...
Published on May 30, 2019in Epigenomics 4.40
Véronique Desgagné6
Estimated H-index: 6
(Université de Sherbrooke),
Renée Guérin4
Estimated H-index: 4
(Université de Sherbrooke)
+ 8 AuthorsBenoit J. Arsenault34
Estimated H-index: 34
(Laval University)
Published on Apr 1, 2019
Audrey-Anne Després (Laval University), Nicolas Perrot2
Estimated H-index: 2
(Laval University)
+ 20 AuthorsJean Guimond5
Estimated H-index: 5
Abstract Background Lipoprotein(a) (Lp[a]) is the preferential lipoprotein carrier of oxidized phospholipids (OxPLs) and a well-established genetic risk factor for calcific aortic valve stenosis (CAVS). Whether Lp(a) predicts aortic valve microcalcification in individuals without CAVS is unknown. Our objective was to estimate the prevalence of elevated Lp(a) and OxPL levels in patients with CAVS and to determine if individuals with elevated Lp(a) but without CAVS have higher aortic valve microca...
Published on May 1, 2019in Journal of the American College of Cardiology 18.64
Kang H. Zheng1
Estimated H-index: 1
(AMC: Academic Medical Center),
Sotirios Tsimikas68
Estimated H-index: 68
(UCSD: University of California, San Diego)
+ 16 AuthorsJesper Hjortnaes10
Estimated H-index: 10
Abstract Background Lipoprotein(a) [Lp(a)], a major carrier of oxidized phospholipids (OxPL), is associated with an increased incidence of aortic stenosis (AS). However, it remains unclear whether elevated Lp(a) and OxPL drive disease progression and are therefore targets for therapeutic intervention. Objectives This study investigated whether Lp(a) and OxPL on apolipoprotein B-100 (OxPL-apoB) levels are associated with disease activity, disease progression, and clinical events in AS patients, a...
Published on May 1, 2019in European Heart Journal 23.24
Rihab Bouchareb11
Estimated H-index: 11
(Laval University),
Marie-Chloé Boulanger17
Estimated H-index: 17
(Laval University)
+ 10 AuthorsPhilippe Pibarot74
Estimated H-index: 74
(Laval University)